Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Moodys
Fuji
Johnson and Johnson
UBS
Citi
Baxter
Daiichi Sankyo
Federal Trade Commission

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018300

« Back to Dashboard

NDA 018300 describes HIBISTAT, which is a drug marketed by Molnlycke Hlth and is included in one NDA. It is available from one supplier. Additional details are available on the HIBISTAT profile page.

The generic ingredient in HIBISTAT is chlorhexidine gluconate. There are fifty-seven drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
Summary for 018300
Tradename:HIBISTAT
Applicant:Molnlycke Hlth
Ingredient:chlorhexidine gluconate
Patents:0
Therapeutic Class:Dental and Oral Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018300
Suppliers and Packaging for NDA: 018300
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HIBISTAT chlorhexidine gluconate SOLUTION;TOPICAL 018300 NDA Mölnlycke Health Care US, LLC 0234-0587 N 0234-0587-17
HIBISTAT chlorhexidine gluconate SOLUTION;TOPICAL 018300 NDA Mölnlycke Health Care US, LLC 0234-0587 N 0234-0587-27

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION;TOPICALStrength0.5%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fish and Richardson
Moodys
Mallinckrodt
Johnson and Johnson
Cipla
Citi
Deloitte
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.